Tower Research Capital LLC (Trc) Cytosorbents Corp Call Options Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CTSO
# of Institutions
56Shares Held
16.4MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.74 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$3.37 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.36 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$2.04 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.51 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $52.7M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...